OQY-3258, also known as ESG401, is an anti-TROP2 ADC currently under evaluation in three clinical trials: A Phase 1a/1b clinical trial for patients with solid tumors (NCT04892342). A Phase 3 study in ...

Among 15 leading service providers evaluated, Concentrix earned Highest Leader positioning, based on market impact, the ability to deliver services successfully, its strategic integration of AI ...

During busy times on an average day at Heathrow Airport, planes can land as often as one every 45 seconds. Serving more than ...

We are a reader-supported site and receive compensation from purchases made through these links. See more about our Privacy ...

Voyageur Mineral Explorers Corp. ("Voyageur" or the "Company") is pleased to announce its intention to commence a normal course issuer bid (the "NCIB"), under which it may purchase up to an aggregate ...